Respiratory Physiology Diagnostics North East Glasgow Roger Carter Consultant Clinical Scientist.

Slides:



Advertisements
Similar presentations
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Is it really COPD? Dr Rod Taylor Consultant Respiratory Physician Calderdale Royal Hospital Dr Rod Taylor Consultant Respiratory Physician Calderdale Royal.
or more simply.. -asthma is a condition of paroxysmal reversible airway obstruction which is characterised by : Airflow limitation ( reversible) Airway.
Kelly Backler Lead Respiratory Physiologist, Hinchingbrooke Hospital
2012 UPDATE. What guidelines do we have available to follow for asthma 1) Asthma GP monitoring Guideline 2) Asthma Diagnosis Guideline 3) Acute asthma.
Academy Board Prep PCCM
นส. นุชนาถ ตั้งเวนิช เจริญสุข รหัส A chronic inflammatory disorder of the airway Airway hyperresponsiveness Recurrent episodes of wheezing,
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Oxygen assessment and provision Anne McGown Consultant Royal Berkshire Hospital Mar 2008.
Professor of Respiratory Medicine
LUNG FUNCTION IN HEALTH AND DISEASE: SPIROMETRY Sultan Ayoub Meo MBBS, PGC Med Ed, PG Dip Med Ed, M.Phil, Ph.D Professor, Department of Physiology, College.
Identifying COPD in primary care: targeting patients at the highest risk What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
Applied Epidemiology Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) By Chris Callan 23 April 2008.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD Juliana Tambellini University of Pittsburgh.
COPD (Chronic Obstructive Pulmonary Disease)
Management of Patients With Chronic Pulmonary Disease.
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Chronic obstructive pulmonary disease (COPD) Professor Bill MacNee
Deep breath and blow - the HCA role in respiratory care
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
Respiratory Impairment and Disability A. H. Mehrparvar, M.D.
Chronic Obstructive Pulmonary Disease. Why COPD is Important ? COPD is the only chronic disease that is showing progressive upward trend in both mortality.
Chronic Obstructive Pulmonary Disease
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
Respiratory Function Tests Fiona Gilmour SHO 03/06/04.
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
Respiratory COPD/Asthma.
يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11 بسم الله الرحمن الرحیم با سلام.
Lung Function Tests Normal and abnormal Prof. J. Hanacek, MD, PhD.
Assessing Risk (Future) Domain – Of adverse events in the future, especially of exacerbations and of progressive, irreversible loss of pulmonary function—is.
Normal and abnormal Prof. J. Hanacek, MD, PhD
LUNG FUNCTIONS IN HEALTH AND DISEASE Prof. Sultan Ayoub Meo MBBS, M.Phil, Ph.D (Pak), PG Dip Med Ed (Scotland) FRCP (London), FRCP (Dublin), FRCP (Glasgow),
1 Pulmonary Function Tests J.B. Handler, M.D. Physician Assistant Program University of New England.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Component 1: Measures of Assessment and Monitoring n Two aspects: –Initial assessment and diagnosis of asthma –Periodic assessment and monitoring.
Implementing the Respiratory Health and Wellbeing Service Framework Through the Development of Nurses and Midwives Angela Drury Senior Professional Officer,
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
Chronic Obstructive Pulmonary Disease Austin Paul K.
Pulmonary Function Tests Eloise Harman. Symptoms of Lung Disease Cough, productive or unproductive Increased sensitivity to odors and irritants Pleuritic.
Exacerbations. Exacerbations An exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond.
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Establish consultant availability Establish a single Appointment Centre Model clinical service delivery Focus on follow ups Focus on patient information.
Maggie Harris Independent Respiratory Nurse Specialist
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
Pulmonary function test. Evaluation of pulmonary function is important in many clinical situations evaluation of a variety of forms of lung disease assessing.
Chronic Obstructive Pulmonary Disease. COPD is an umbrella term for two diseases which cause progressive airflow obstruction Chronic Bronchitis- Inflammation.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Asthma 1 د. ميريانا البيضة. DIAGNOSIS 2 3 Definition of asthma.
Survey of Respiratory Diagnostic Laboratories to Inform the National COPD Strategy T McCarthy,* A McGowan, ¥ M O’Connor,* on behalf of the National COPD.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
Blueprint COPD Services (1/2) 1 Health and Wellbeing Self and Informal Care New Primary Care  New anti-smoking campaign, well-coordinated and consistent.
Effect of primary-care spirometry on the diagnosis and management of COPD P.P. Walker, P. Mitchell, F. Diamantea, C.J. Warburton and L. Davies Eur Respir.
COPD 2003.
Chronic Obstructive Pulmonary Disease(COPD)
Jessica Case study.
Lung function in health and disease
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
Greater Glasgow Outreach Spirometry Service: A model for closer collaboration between primary and secondary care and its impact on chronic lung disease.
COPD Dr MAMATHA SARTHI GPST3.
COPD, OPIOIDs, DMARDs.
Prof Dr Guy JOOS Dept Respiratory Medicine Ghent University Hospital
بیماریهای مزمن انسدادی ریه COPD
Diagnosi della BPCO 1.
PALLIATIVE CARE FOR COPD PATIENTS:
Nottingham City Care Integrated Respiratory Service and Home Oxygen Service Zoe Styles Senior Physiotherapist.
Presentation transcript:

Respiratory Physiology Diagnostics North East Glasgow Roger Carter Consultant Clinical Scientist

The service we provide : The North East Glasgow Hospitals provide lung function service to a local population of 350,000 A wide range of diagnostic respiratory physiology services are delivered from two dedicated respiratory physiology laboratories based at Glasgow Royal Infirmary and Stobhill Hospital. In total 42 respiratory/ sleep investigations have been coded : The following investigations are offered at both sites: Spirometry ** Bronchodilator Assessment** Lung Volumes by Body Plethysmography Transfer Factor and components Ear lobe capillary blood gases LTOT Assessment Ambulatory Oxygen Assessment Flight Assessment Bronchial Reactivity Cardio-Pulmonary Exercise Testing Surgical Risk Assessment Nebuliser Assessment Nebuliser Exchange Service Outreach Spirometry (GP Flow Volume Loops)** Respiratory Muscle Assessment Respiratory Drive Sniff Pressures

Volume Time Curves Time (Seconds) Volume (Litres) FEV 1 Normal Obstructive Severe Obstruction Restrictive

Flow Volume Loops - Emphysema

SYMPTOMS cough sputum dyspnea EXPOSURE TO RISK FACTORS tobacco occupation indoor/outdoor pollution SPIROMETRY Diagnosis of COPD è è

NICE COPD 2004: Severity of obstruction FEV 1 /FVC <70% FEV 1 =50% Predicted: Mild airflow obstruction FEV 1 =30% Predicted: Moderate airflow obstruction FEV 1 <30% Predicted: Severe airflow obstruction

Diagnosis: Asthma The diagnosis of asthma is based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative explanation for them. If high probability - trial of treatment Low/Moderate - attempt to find airflow obstruction (Spirometry with reversibility to acute bronchodilator administration)

Intermediate Probability of Asthma In view of lifelong treatment seek objective evidence of airflow obstruction Spirometry is preferred over peak flow at diagnosis Caveat - normal spirometry if asymptomatic does not exclude asthma Peak flow diaries demonstrating airflow variability are helpful

Management of stable COPD Healthy population Smokers cough Little or no dyspnoea No abnormal signs Exertional dyspnoea Cough & sputum Some abnormal signs Dyspnoea on mild exertion Hyperinflation & cyanosis Wheeze & cough Death Worsening lung function FEV 1 as % predicted Increasing investigation and treatment Smoking cessation Antibiotics for acute infections Trial Symptomatic bronchodilator therapy Trial Long acting Bronchodilators Inhaled steroid if freq exacerbations Influenza vaccination Pulmonary rehabilitation Assessment for LTOT Symptoms

Waiting Times: Spirometry 2007 –Average Waiting Time 9 weeks –Longest Waiting Time 12 weeks

Make a difference by : Introduction of efficient administrative systems to manage the booking system more effectively and improve local pathways. Reduction of waiting times by actively managing the booking of diagnostic respiratory tests and the use of first available spirometry slot at any north east site.

Making a difference: what we did : Previously appointments for the service were booked onto a paper diary list by an assistant technical officer. We have developed electronic clinic templates for Respiratory Diagnostic testing on the PAS system. These are, at present, appointed by clinical physiologists. This has enabled: – Flexible booking system - better time management relative to the type of tests and specialty clinics. – Record accurate data on patient administration system. Owing to the complexity and time consuming nature of some of the investigations, short notice patient cancellation or non-attendance are particularly wasteful of resources and this can occur on a regular basis. Patients who cancelled appointments were regularly offered repeat appointments, increasing the length of the waiting list and reducing the availability of slots. The administrative team actively applied the health board’s waiting list policy so that patients who do not attend or cancel their appointment twice are removed from the waiting list and returned to their referrer with an explanation of the action. Also patients who decline two or more reasonable notice appointments, but still wish to be investigated, are clearly flagged under patient choice and do not reflect in the waiting list statistics.

What benefits did we achieve? Streamlined patient booking pathway therefore better patient experience. The ability to offer first available appointment at either laboratory (two laboratories but single service) if the patient was prepared to travel or the most appropriate site at the patient’s request Reduced number of patients arriving without referral forms and patients are better informed (Clinical Portal Access) Flexible booking times – increased capacity for one-stop clinics. A reduction in cancellations and DNAs. A reduction in waiting times. Involvement in the Diagnostic Working Group to review the waiting list policy and the inclusion of diagnostic services in to the waiting list policy (DMMI) Improved staff awareness of current waiting lists and activity through the publication, by the department manager, of monthly statistics.

How we measured the achievement? Data analysis from PAS. Reduced waiting times for new patients from 9 weeks to approximately 4 weeks. Increased one-stop clinics due to better time management by physiologists. Reduced waiting times were observed in the monthly returns Tables indicating the waiting time trends and including activity, referral and patient DNAs.

Example Table: Number of patients waiting, listed by period, since the date orv receipt of referral for the test, as at last day of the month: SPIROMETRY Wait Days Weeks >92 >13 NOV NOV FEB

What challenges did we face in making this idea work for us? The transfer of appointments from the paper diary to the PAS system involved a concerted effort of clinical physiologist time. Natural scepticism of clinical physiologist staff in initiating this booking system and the move away from a paper diary Training the clinical physiologist staff to manage our investigation bookings in line with additional information being provided by the waiting list tables, whilst still maintaining a sensible rationale for patients with different indicated clinical urgency. Ensuring all multiple cancellation and DNA patients were managed in accordance with the Trust waiting list policy and where there was any ambiguity to discuss each case with the Consultant Clinical Scientist

Further Development A dedicated administrator appointment to manage patient bookings: –Freeing of clinical physiologist time presently spent on doing routine administrative tasks to perform respiratory diagnostics with a proposed further fall in waiting times. Introduction of electronic booking of respiratory diagnostic tests through the clinical portal with associated reduction in paper referrals and reduction in time spent in obtaining referrals through the internal mail. Scoping of all respiratory physiology/sleep diagnostic tests (42 in total) to address 18 weeks RTT